Home LiteratureArticle Details
PMID: 15951843 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.

The Journal of clinical investigation ·Vol. 115 ·No. 7 ·2005-07-00 ·Pages 1816-27

Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura D

Abstract

NO has been shown to mediate angiogenesis; however, its role in vessel morphogenesis and maturation is not known. Using intravital microscopy, histological analysis, alpha-smooth muscle actin and chondroitin sulfate proteoglycan 4 staining, microsensor NO measurements, and an NO synthase (NOS) inhibitor, we found that NO mediates mural cell coverage as well as vessel branching and longitudinal extension but not the circumferential growth of blood vessels in B16 murine melanomas. NO-sensitive fluorescent probe 4,5-diaminofluorescein imaging, NOS immunostaining, and the use of NOS-deficient mice revealed that eNOS in vascular endothelial cells is the predominant source of NO and induces these effects. To further dissect the role of NO in mural cell recruitment and vascular morphogenesis, we performed a series of independent analyses. Transwell and under-agarose migration assays demonstrated that endothelial cell-derived NO induces directional migration of mural cell precursors toward endothelial cells. An in vivo tissue-engineered blood vessel model revealed that NO mediates endothelial-mural cell interaction prior to vessel perfusion and also induces recruitment of mural cells to angiogenic vessels, vessel branching, and longitudinal extension and subsequent stabilization of the vessels. These data indicate that endothelial cell-derived NO induces mural cell recruitment as well as subsequent morphogenesis and stabilization of angiogenic vessels.

MeSH Terms
Animals Cells, Cultured Endothelial Cells/pathology Enzyme Inhibitors/pharmacology Gene Expression Humans Melanoma, Experimental/blood supply,drug therapy,pathology Mice Mice, Inbred C57BL Mice, Knockout Mice, SCID Neovascularization, Pathologic/drug therapy Neovascularization, Physiologic Nitric Oxide/physiology Nitric Oxide Synthase/antagonists & inhibitors,deficiency,genetics Tissue Engineering omega-N-Methylarginine/pharmacology
Chemicals
Enzyme Inhibitors omega-N-Methylarginine Nitric Oxide Nitric Oxide Synthase
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Kashiwagi Satoshi
Edwin L. Steele Laboratory, Department of Radiation Oncology, and Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Izumi Yotaro
Gohongi Takeshi
Demou Zoe N
Xu Lei
Huang Paul L
Buerk Donald G
Munn Lance L
Jain Rakesh K
Fukumura Dai
References (62)
62 references, click to expand
  1. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway.
    Acta Physiol Scand. 1992 Jul;145(3):201-27 PMID: 1381545
  2. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.
    Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1086-92 PMID: 12117721
  3. The implications of angiogenesis for the biology and therapy of cancer metastasis.
    Cell. 1994 Oct 21;79(2):185-8 PMID: 7525076
  4. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
    J Clin Invest. 1994 Nov;94(5):2036-44 PMID: 7525653
  5. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1.
    Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1255-61 PMID: 7543000
  6. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli.
    Microvasc Res. 1996 Jul;52(1):13-26 PMID: 8812749
  7. Pericytes in the microvasculature.
    Cardiovasc Res. 1996 Oct;32(4):687-98 PMID: 8915187
  8. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.
    Cell. 1996 Dec 27;87(7):1171-80 PMID: 8980224
  9. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.
    Circulation. 1997 Feb 18;95(4):1030-7 PMID: 9054767
  10. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF.
    Circ Res. 1997 Jun;80(6):845-52 PMID: 9168787
  11. Nitric oxide in the vasculature: physiology and pathophysiology.
    Ann N Y Acad Sci. 1997 Apr 15;811:60-7; discussion 67-9 PMID: 9186585
  12. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.
    Science. 1997 Jul 11;277(5323):242-5 PMID: 9211853
  13. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
    J Clin Invest. 1997 Dec 15;100(12):3131-9 PMID: 9399960
  14. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore.
    Chem Pharm Bull (Tokyo). 1998 Feb;46(2):373-5 PMID: 9501473
  15. Role of nitric oxide in angiogenesis and microcirculation in tumors.
    Cancer Metastasis Rev. 1998 Mar;17(1):77-89 PMID: 9544424
  16. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.
    J Natl Cancer Inst. 1998 Apr 15;90(8):587-96 PMID: 9554441
  17. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate.
    J Cell Biol. 1998 May 4;141(3):805-14 PMID: 9566978
  18. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
    J Clin Invest. 1998 Jun 1;101(11):2567-78 PMID: 9616228
  19. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells.
    Nat Med. 1998 Dec;4(12):1371-6 PMID: 9846573
  20. Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA.
    Neuroreport. 1998 Oct 26;9(15):3345-8 PMID: 9855277
  21. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact.
    Circ Res. 1999 Feb 19;84(3):298-305 PMID: 10024303
  22. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology.
    Circ Res. 1999 Apr 2;84(6):655-67 PMID: 10189353
  23. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.
    Nature. 1999 Jun 10;399(6736):601-5 PMID: 10376603
  24. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors.
    Am J Pathol. 1999 Oct;155(4):1381-90 PMID: 10514420
  25. Nitric oxide as a signaling molecule in the vascular system: an overview.
    J Cardiovasc Pharmacol. 1999 Dec;34(6):879-86 PMID: 10598133
  26. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells.
    Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):659-66 PMID: 10712388
  27. Angiogenesis in cancer and other diseases.
    Nature. 2000 Sep 14;407(6801):249-57 PMID: 11001068
  28. Direct imaging of NMDA-stimulated nitric oxide production in the retina.
    Vis Neurosci. 2000 Jul-Aug;17(4):557-66 PMID: 11016575
  29. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.
    J Clin Invest. 2000 Oct;106(8):951-61 PMID: 11032855
  30. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
    Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2604-9 PMID: 11226286
  31. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion.
    Int J Cancer. 2001 Mar 1;91(5):607-11 PMID: 11267968
  32. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells.
    J Biol Chem. 2001 Apr 13;276(15):12420-6 PMID: 11278407
  33. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
    Cancer Res. 2001 Apr 1;61(7):3182-7 PMID: 11306506
  34. Cell-cell interactions in vascular development.
    Curr Top Dev Biol. 2001;52:107-49 PMID: 11529428
  35. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?
    J Pharmacol Exp Ther. 2001 Dec;299(3):818-24 PMID: 11714864
  36. Analysis of mural cell recruitment to tumor vessels.
    Circulation. 2002 Jan 1;105(1):112-7 PMID: 11772885
  37. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.
    Am J Pathol. 2002 Mar;160(3):985-1000 PMID: 11891196
  38. Nitric oxide is proangiogenic in the retina and choroid.
    J Cell Physiol. 2002 Apr;191(1):116-24 PMID: 11920687
  39. Dissecting tumour pathophysiology using intravital microscopy.
    Nat Rev Cancer. 2002 Apr;2(4):266-76 PMID: 12001988
  40. Fully automated three-dimensional tracking of cancer cells in collagen gels: determination of motility phenotypes at the cellular level.
    Cancer Res. 2002 Sep 15;62(18):5301-7 PMID: 12235000
  41. Nonendothelial source of nitric oxide in arterioles but not in venules: alternative source revealed in vivo by diaminofluorescein microfluorography.
    Circ Res. 2002 Dec 13;91(12):e55-64 PMID: 12480826
  42. Melanoma development and progression: a conspiracy between tumor and host.
    Differentiation. 2002 Dec;70(9-10):522-36 PMID: 12492494
  43. Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration.
    Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3404-9 PMID: 12621153
  44. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide.
    Am J Pathol. 2003 Jun;162(6):1927-36 PMID: 12759249
  45. Molecular regulation of vessel maturation.
    Nat Med. 2003 Jun;9(6):685-93 PMID: 12778167
  46. Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta.
    J Clin Invest. 1992 Mar;89(3):878-82 PMID: 1311719
  47. Impaired wound healing and angiogenesis in eNOS-deficient mice.
    Am J Physiol. 1999 Oct;277(4 Pt 2):H1600-8 PMID: 10516200
  48. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.
    Science. 2005 Jan 7;307(5706):58-62 PMID: 15637262
  49. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.
    Cancer Cell. 2003 Jul;4(1):31-9 PMID: 12892711
  50. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis.
    Circ Res. 2003 Oct 31;93(9):e88-97 PMID: 14525808
  51. Endothelial-pericyte interactions in angiogenesis.
    Cell Tissue Res. 2003 Oct;314(1):15-23 PMID: 12883993
  52. Cancer without disease.
    Nature. 2004 Feb 26;427(6977):787 PMID: 14985739
  53. Tissue engineering: creation of long-lasting blood vessels.
    Nature. 2004 Mar 11;428(6979):138-9 PMID: 15014486
  54. Recent advances in melanoma biology.
    Oncologist. 2004;9(2):182-7 PMID: 15047922
  55. Role of eNOS in neovascularization: NO for endothelial progenitor cells.
    Trends Mol Med. 2004 Apr;10(4):143-5 PMID: 15162796
  56. iNOS-mediated nitric oxide production and its regulation.
    Life Sci. 2004 Jun 25;75(6):639-53 PMID: 15172174
  57. Biological significance of nitric oxide-mediated protein modifications.
    Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L262-8 PMID: 15246980
  58. Selection of successive tumour lines for metastasis.
    Nat New Biol. 1973 Apr 4;242(118):148-9 PMID: 4512654
  59. Pericytes, like vascular smooth muscle cells, are immunocytochemically positive for cyclic GMP-dependent protein kinase.
    Microvasc Res. 1984 Sep;28(2):206-19 PMID: 6094989
  60. Determinants of tumor blood flow: a review.
    Cancer Res. 1988 May 15;48(10):2641-58 PMID: 3282647
  61. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.
    Am J Pathol. 1991 Jun;138(6):1335-47 PMID: 1711288
  62. Nitric oxide synthases: roles, tolls, and controls.
    Cell. 1994 Sep 23;78(6):915-8 PMID: 7522969
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2005-07-00
Epub
2005-00-09
Pages
1816-27
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1143589
Subset
IM
Grants
NCI NIH HHS · R01-CA96915 · United States
NHLBI NIH HHS · HL-068164 · United States
NCI NIH HHS · P01 CA080124 · United States
NCI NIH HHS · R24-CA85140 · United States
NCI NIH HHS · R24 CA085140 · United States
NCI NIH HHS · R01 CA096915 · United States
NHLBI NIH HHS · R01 HL068164 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com